Frédérik Oger

ORCID: 0000-0003-0006-5835
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic function and diabetes
  • Histone Deacetylase Inhibitors Research
  • Epigenetics and DNA Methylation
  • Adipose Tissue and Metabolism
  • Metabolism, Diabetes, and Cancer
  • RNA modifications and cancer
  • Parasites and Host Interactions
  • Cancer-related gene regulation
  • Diabetes Treatment and Management
  • Estrogen and related hormone effects
  • Diabetes and associated disorders
  • Genomics and Chromatin Dynamics
  • Nuclear Receptors and Signaling
  • Protein Degradation and Inhibitors
  • Peroxisome Proliferator-Activated Receptors
  • Genetics and Neurodevelopmental Disorders
  • Birth, Development, and Health
  • Cancer, Lipids, and Metabolism
  • Cancer-related molecular mechanisms research
  • Cancer-related Molecular Pathways
  • Drug Transport and Resistance Mechanisms
  • Error Correcting Code Techniques
  • Mass Spectrometry Techniques and Applications
  • Peptidase Inhibition and Analysis
  • Cholinesterase and Neurodegenerative Diseases

Inserm
2011-2024

Université de Lille
2012-2024

Institut Pasteur de Lille
2011-2024

Centre Hospitalier Universitaire de Lille
2017-2024

Centre National de la Recherche Scientifique
2009-2024

European Genomic Institute for Diabetes
2013-2023

(Epi)génomique fonctionnelle métabolique et des dysfonctions dans le diabète de type 2 et des maladies associées
2020-2022

Université Lille Nord de France
2009-2012

Université de Rennes
2009-2012

Physique des interactions ioniques et moléculaires
2007

Enhancers are developmentally controlled transcriptional regulatory regions whose activities modulated through histone modifications or variant deposition. In this study, we show by genome-wide mapping that the newly discovered deoxyribonucleic acid (DNA) modification 5-hydroxymethylcytosine (5hmC) is dynamically associated with transcription factor binding to distal sites during neural differentiation of mouse P19 cells and adipocyte 3T3-L1 cells. Functional annotation reveals gaining 5hmC...

10.1093/nar/gks595 article EN cc-by-nc Nucleic Acids Research 2012-06-21

CCCTC-binding factor (CTCF) is a ubiquitously expressed multifunctional transcription characterized by chromatin binding patterns often described as largely invariant. In this context, how CTCF recruitment and functionalities are used to promote cell type-specific gene expression remains poorly defined. Here, we show that, in addition constitutively bound sites (CTS), the cistrome comprises large proportion of showing highly dynamic during course adipogenesis. Interestingly, positively...

10.1093/nar/gku780 article EN cc-by-nc Nucleic Acids Research 2014-09-02

Obesity is characterized by the excessive accumulation of dysfunctional white adipose tissue (WAT), leading to a strong perturbation metabolic regulations. However, molecular events underlying this process are not fully understood.MicroRNAs (miRNAs) small noncoding RNAs acting as posttranscriptional regulators gene expression in multiple tissues and organs. their roles WAT cell subtypes, which include only adipocytes but also immune, endothelial, mesenchymal stem cells well preadipocytes,...

10.1210/jc.2013-4259 article EN The Journal of Clinical Endocrinology & Metabolism 2014-04-23

Genome-wide association studies have reported that DNA polymorphisms at the CDKN2A locus modulate fasting glucose in human and contribute to type 2 diabetes (T2D) risk. Yet causal relationship between this gene defective energy homeostasis remains elusive. Here we sought understand contribution of Cdkn2a metabolic homeostasis. We first analyzed from Cdkn2a-deficient mice subjected normal or high fat diets. Subsequently primary adipose cells human-induced pluripotent stem differentiated into...

10.1016/j.molmet.2017.11.012 article EN cc-by-nc-nd Molecular Metabolism 2017-12-02

Adipocyte differentiation and function relies on a network of transcription factors, which is disrupted in obesity-associated low grade, chronic inflammation leading to adipose tissue dysfunction. In this context, there need for thorough understanding the transcriptional regulatory involved pathophysiology. Recent advances functional annotation genome has highlighted role non-coding RNAs cellular processes coordination with factors. Using an unbiased genome-wide approach, we identified...

10.1038/s41598-017-14570-y article EN cc-by Scientific Reports 2017-10-20

According to the Developmental Origin of Health and Disease (DOHaD) concept, maternal obesity accelerated growth in neonates predispose offspring white adipose tissue (WAT) accumulation. In rodents, adipogenesis mainly develops during lactation. The mechanisms underlying phenomenon known as developmental programming remain elusive. We previously reported that adult rat from high-fat diet-fed dams (called HF) exhibited hypertrophic adipocyte, hyperleptinemia increased leptin mRNA levels a...

10.1016/j.molmet.2017.05.010 article EN cc-by-nc-nd Molecular Metabolism 2017-06-01

Type 2 diabetes is characterized by chronic hyperglycemia associated with impaired insulin action and secretion. Although the heritability of type high, environment, including blood components, could play a major role in development disease. Amongst environmental effects, epitranscriptomic modifications have been recently shown to affect gene expression glucose homeostasis. The epitranscriptome reversible chemical changes RNA, one most prevalent being m6A methylation RNA. Since pancreatic β...

10.3390/cells11020291 article EN cc-by Cells 2022-01-15

The nuclear receptor peroxisome proliferator-activated gamma (PPAR γ ) is required for differentiation and function of mature adipocytes. Its expression induced during adipogenesis where it plays a key role in establishing the transcriptome terminally differentiated white fat cells. Here, we review findings indicating that PPAR activity are intricately regulated through control chromatin structure. Hierarchical combinatorial activation transcription factors, noncoding RNAs, remodelers allows...

10.1155/2012/164140 article EN cc-by PPAR Research 2012-01-01

Only one drug is currently available for the treatment and control of schistosomiasis increasing risk selecting strains schistosome that are resistant to praziquantel means development new drugs urgent. With this objective we have chosen target enzymes modifying histones in particular histone acetyltransferases deacetylases (HDAC). Inhibitors HDACs (HDACi) under intense study as potential anti-cancer act via induction cell cycle arrest and/or apoptosis. Schistosomes like other parasites can...

10.1590/s0074-02762011000700003 article EN Memórias do Instituto Oswaldo Cruz 2011-11-01

According to the Developmental Origin of Health and Disease (DOHaD) concept, maternal obesity accelerated growth in neonates program later life. White adipose tissue (WAT) has been focus developmental programming events, although underlying mechanisms remain elusive. In rodents, WAT development primarily occurs during lactation. We previously reported that adult rat offspring from dams fed a high-fat (HF) diet exhibited fat accumulation decreased peroxisome proliferator-activated receptor γ...

10.1096/fj.201700997r article EN The FASEB Journal 2018-01-02

Inhibition of histone deacetylases (HDACs) leads to growth arrest, differentiation, or apoptosis tumor cell lines, suggesting HDACs as promising targets for cancer therapy. At present, only one HDAC inhibitor (HDACi) is used in therapy: suberoylanilide hydroxamic acid (SAHA). Here, we describe the synthesis and biological evaluation a new series compounds derived from SAHA by substituting short alkyl chains at various positions phenyl ring. Such modifications induced variable effects ranging...

10.1021/jm901561u article EN Journal of Medicinal Chemistry 2010-02-09

Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII/NR2F2) is an orphan member of the nuclear receptor family transcription factors whose activities are modulated upon binding small molecules into hydrophobic ligand-binding pocket (LBP). Although LBP COUP-TFII filled with aromatic amino-acid side chains, alternative modes ligand could potentially lead to regulation receptor. Here, we screened a synthetic and natural compound library in yeast one-hybrid assay identified...

10.1021/acschembio.6b00593 article EN ACS Chemical Biology 2017-01-06

The glucagon-like peptide 1 (Glp-1) has emerged as a hormone with broad pharmacological potential in type 2 diabetes (T2D) treatment, notably by improving β cell functions. cell-cycle regulator and transcription factor E2f1 is involved glucose homeostasis modulating mass function. Here, we report that cell-specific genetic ablation of (E2f1β−/−) impairs associated decreased expression the Glp-1 receptor (Glp1r) E2f1β−/− pancreatic islets. Pharmacological inhibition E2F1 transcriptional...

10.1016/j.celrep.2022.111170 article EN cc-by-nc-nd Cell Reports 2022-08-01

Type 2 diabetes (T2D) is a metabolic disorder characterized by loss of pancreatic β-cell function, decreased insulin secretion and increased resistance, that affects more than 537 million people worldwide. Although several treatments are proposed to patients suffering from T2D, long-term control glycemia remains challenge. Therefore, identifying new potential drugs targets positively affect function crucial. Here, we developed an automated approach allow the identification compounds or genes...

10.3390/cells12060849 article EN cc-by Cells 2023-03-09

The loss of pancreatic β-cell identity has emerged as an important feature type 2 diabetes development, but the molecular mechanisms are still elusive. Here, we explore cell-autonomous role cell-cycle regulator and transcription factor E2F1 in maintenance identity, insulin secretion, glucose homeostasis. We show that β-cell–specific E2f1 function mice triggers intolerance associated with defective altered endocrine cell mass, downregulation many genes, concomitant increase non–β-cell...

10.2337/db22-0604 article EN Diabetes 2023-05-22

The human pregnane X receptor (PXR) is a ligand-regulated transcription factor belonging to the nuclear superfamily. PXR activated by large, structurally diverse, set of endogenous and xenobiotic compounds coordinates expression genes central metabolism excretion potentially harmful chemicals therapeutic drugs in humans. Walrycin A novel antibacterial compound targeting WalK/WalR two-component signal transduction system Gram (+) bacteria. Here, we report that, hepatoma cells, walrycin...

10.1093/toxsci/kfs073 article EN Toxicological Sciences 2012-02-07
Coming Soon ...